E n d o s c o p i c u l t r a s o u n d v e r s u s m a g n e t i c resonance cholangiopancreatography in suspected choledocholithiasis: A systematic review
the optimal noninvasive strategies for patients with suspected common bile duct (CBD) stones after a negative transabdominal ultrasound (US) and/ or computed tomography. Endoscopic retrograde cholangiopancreatography (ERCP) continues to be considered the standard of reference for detection of bile duct stones with the possibility of simultaneous treatment. [3] Nevertheless, ERCP remains an invasive method. [4] Low-risk tests such as endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) have emerged as reliable substitutes for diagnostic ERCP. [5] [6] [7] [8] [9] [10] A few reports have compared the diagnostic ability of CBD stones between EUS and MRCP. [11] [12] [13] [14] [15] [16] [17] Two previous systematic reviews demonstrated no statistically significant difference between EUS and MRCP in terms of the detection of choledocholithiasis although both tests were highly effective. [18, 19] Since the last systematic review, one new prospective study has emerged, accounting for new data with an increased sample population higher than 30%. [20] The aim of this study was to compare the diagnostic ability of EUS and MRCP in cases of suspected choledocholithiasis using data from published comparative studies.
MATERIALS AND METHODS

Protocol and registration
This systematic review of the literature was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. [21] The review was registered on the PROSPERO international database (www.crd.york.ac.uk/ prospero/) under number CRD42014014670.
Eligibility criteria
a. Types of studies: We focused on prospective comparative trials (clinical trials and/or observational studies). b. T y p e s o f p a r t i c i p a n t s : Pa t i e n t s i n w h o m choledocholithiasis was suspected with similar population characteristics (age, sex distribution, and clinical indication for the test). c. Types of intervention: Studies comparing the outcomes in two diagnostic arms: EUS and MRCP. Both EUS and MRCP were performed for the diagnosis of extrahepatic biliary obstruction followed by one or more of the confirmatory criterion standard tests (ERCP or intraoperative cholangiography with or without cholangioscopy) that were accepted as criterion standards in all studies. Both procedures were performed temporally close together (24-72 h in most cases) to minimize the chances of a negative study from stone passage. There were no restrictions regarding different technique modalities in each arm except for the blinding of the endosonographer and the radiologist evaluating the patients. d. Types of outcome measures: The main outcomes measures were accuracy, sensitivity, specifi city, positive predictive value (PPV), and negative predictive value (NPV).
Information sources
Studies were identifi ed by searching several electronic databases and scanning the reference lists of articles. This search was applied for Medline (inclusive of all years) and EMBASE. The Cochrane, LILACS (via BVS), Scopus, and CINAHL (via EBSCO) databases were also reviewed. A manual search was also conducted for relevant reviews, original articles, and abstract books. The last search was run on May 22, 2015; no language limits were applied.
Search
Comparative trials were identified by conducting a comprehensive search of electronic databases using medical subject headings (MESH) stratified by population -"choledocholithiasis," intervention -"endosonography," and comparison -"magnetic resonance cholangiopancreatography." We further searched the bibliographies of all the included primary studies and existing reviews by hand for additional citations.
Study selection
We performed the eligibility assessment and the selection of screened records independently in an unblended, standardized manner with two reviewers. Disagreements between the reviewers were resolved by a consensus.
To summarize the study selection processes, we used an adapted PRISMA fl ow diagram [ Figure 1 ].
Data collection process
The method of data extraction from each included study consisted of filling out information sheets after the paper was read. We used a QUADAS-based checklist. [22] One review author extracted the data from the included studies and a second author checked the extracted data. Disagreements were resolved via a discussion between the two review authors.
Data items
The following data items were extracted from each included study: 
Risk of bias in individual studies
To evaluate the risk of bias and applicability of the primary diagnostic accuracy studies, we used the QUADAS-2 tool. [22] This tool is structured so that the four key domains are each rated in terms of the risk of bias and the concern regarding applicability to the research question.
The first domain is patient selection, the second is index test, the third is the reference standard, and the fourth is fl ow and timing.
Summary measures
The primary outcome measures that we focused on included sensitivity, specifi city, pretest probability, PPV and NPV, and accuracy of EUS and MRCP for the detection of choledocholithiasis.
We performed the analysis using the software Review Manager (RevMan) 5.3 obtained from the website of the Cochrane Informatics and Knowledge Management Department. [23] The average data and standard deviation (SD) were obtained using Microsoft Excel software for Windows version 2013.
Risk of bias across studies
QUADAS-2 was applied individually to the selected studies and a global comparative analysis was conducted based on it. Each one of the four key domain tools that included patient selection, index test, reference standard, and flow and timing was filled. We also conducted a comparative analysis of these criteria and checked if the selection of patients, conduct, interpretation of both the index test and reference standard, or patient fl ow could have introduced bias.
RESULTS
Study selection
Two thousand and six hundred and forty-three (2,643) studies were screened and the articles assessed for eligibility were selected after the title and abstract were read. Twenty-two studies compared the performance of EUS and MRCP with regard to the detection of choledocholithiasis. Two thousand and six hundred twentyone (2,621) articles were excluded because they did not include the information outlined above. Fourteen studies were excluded, out of which six did not provide suffi cient data, seven were reviews, and one was an editorial. These characteristics are summarized in Figure 1 . After the last systematic review, one new study has emerged, accounting for 135 patients. [20] Eight published prospective studies that assessed the diagnostic accuracy of EUS and MRCP for the diagnosis of choledocholithiasis in 538 patients were included in our analyses.
Study characteristics
The important characteristics of the selected studies are summarized in Table 1 including the number of patients used in the final analysis. These values were extracted from a careful reading of the included papers. The design, conduct, and outcomes analyses of these studies were similar. The main objective of these studies was to evaluate the performance of EUS and MRCP for the detection of biliary disease, most commonly choledocholithiasis, against criterion standards of ERCP and/or intraoperative cholangiography. The included studies emphasized performing EUS and MRCP temporally close to each other and then evaluating the same patient group with ERCP or intraoperative cholangiography. The procedures were conducted independently, and the individual operators were blinded to the outcome of the results of the other investigation. One of the studies used two subgroups for analysis: Patients with unexplained CBD dilation in standard ultrasonography (US) (Group 1) and patients with a nondilated CBD and a high probability of having choledocholithiasis (Group 2). [20] We subdivided this investigation into two studies in terms of data and included all relevant studies irrespective of their favoring one or the other technique. Table 2 lists the risks of bias included in the studies based on the QUADAS-2 tool.
Risk of bias within studies
All included studies were similar in terms of patient selection and index test risk of bias.
In terms of the reference standard, the results were not interpreted without knowledge of the results of the index test in two studies: Kondo et al. [15] and Schmidt et al. [17] de Lédinghen et al. [11] did not report if their reference standard results were interpreted without knowledge of the results of the index test.
The studies by de Lédinghen et al., [11] Materne et al., [12] Kondo et al., [15] and Fernández-Esparrach et al. [20] reported an inappropriate interval between the index test(s) and the reference standard.
In terms of receiving the same reference standard, Ainsworth et al. [14] and Aube et al. [16] did not introduce bias.
There was a high probability that a patient's flow had introduced bias in the studies of de Lédinghen et al., [11] Materne et al., [12] Kondo et al., [15] and Fernández-Esparrach et al. [20] Results of individual studies Table 3 lists the reported accuracies, sensitivities, specificities, prevalence (pretest probability), and PPV and NPV (posttest probability) in the included studies.
All studies reported an EUS accuracy higher than that of MRCP except for Fernández-Esparrach et al. [20] These authors reported the same accuracy for both methods in Group 1 (95%) and a higher accuracy for MRCP in Group 2 (92% vs. 86%).
All studies reported EUS sensitivity higher than that of MRCP.
The MRCP specificity was higher than EUS in four studies. Scheiman et al., [13] Aube et al. [16] and Schmidt et al. [17] reported the same specifi city in both methods (96.0%, 96.5%, and 94.4%, respectively.) The EUS specificity was higher than that of MRCP in de Lédinghen et al. [11] and Ainsworth et al. [14] In terms of pretest probability, the values varied from 18 to 86.
The EUS PPVs were higher than those of MRCP in four studies. Schmidt et al. [17] reported the same PPVs in both methods (97%).
In terms of the NPVs, those of EUS were higher than those of MRCP in all studies except for de Lédinghen et al. [11] A comparison between EUS and MRCP is shown in Table 4 . For the detection of choledocholithiasis, the sensitivity of EUS was superior to that of MRCP; the former showed an average of 93.7 and SD of 7.1; the latter was characterized by an average of 83.5 and SD of 18.6. The specifi city of EUS was slightly inferior to that of MRCP with an average value of 88.5 and SD of 16.1 versus 91.5 and SD of 10.7. In terms of pretest probability, the mean value was 38.7 with a SD of 21.8. The mean PPV of EUS was 89 with SD of 6.9. For MRCP, the mean value was 87.8 with SD of 14.4. The mean NPV of EUS was 96.9 with SD of 2.6 and the corresponding values for MRCP were a mean value of 87.8 and SD of 15.5. Finally, the aggregated accuracies of EUS were slightly superior to those of MRCP: An average of 93.3 and SD of 1.7 versus 89.7 and SD of 5.0.
Synthesis of results
The receiver operating characteristic (ROC) curve graphically shows the highest accuracy of EUS for diagnosis of choledocholithiasis as well as the sensitivity values according to the specifi city of EUS and MRCP [ Figure 4 ].
Risk of bias across studies
In terms of patient selection, index test, and reference standard, all studies reported a low risk of bias. However, in terms of flow and timing there was a high risk of bias in the studies of de Lédinghen et al., [11] Materne et al., [12] Kondo et al., [15] and Fernández-Esparrach et al. [20] 
DISCUSSION
There has been much recent interest in performing an initial evaluation of patients with suspected choledocholithiasis with less invasive or noninvasive modalities such as EUS and MRCP.
There have been two previous systematic reviews that conducted different methodologies not based in PRISMA recommendations. These reviews demonstrated no statistically signifi cant difference between EUS and MRCP in terms of the detection of choledocholithiasis.
Despite a high aggregated diagnostic accuracy being shown for both modalities, there is no superiority between the tests with respect to sensitivity, specifi city, PPV, and NPV.
ERCP is at present a well-established method for the treatment of pancreatobiliary disease. Since it is associated with a small risk of signifi cant morbidity and mortality, including severe complications such as acute pancreatitis, bleeding, perforation, sepsis, and even but rarely death, its use must be dedicated to treatment instead of diagnosis. [4] We have compared the diagnostic ability of EUS and MRCP to detect choledocholithiasis in suspected patients. This study demonstrated a high diagnostic accuracy of both methods, with the highest sensitivity for EUS and the highest specificity for MRCP.
The major advantage of MRCP is its completely noninvasive nature compared with EUS, perhaps making it a better test for high-risk patients such as the elderly or the severely ill. This study reported a mean MRCP specificity of 91.5 for the detection of choledocholithiasis, demonstrating a very low failure rate. Nevertheless, a high level of technical expertise is crucial to ensure an accurate review of MRCP images and this method requires a high level of patient cooperation. [24] The presence of air bubbles inside the bile duct it is one contributing factor to EUS false negative results. 
Limitations
The gold standard used in a variety of studies has been ERCP although its accuracy is not 100%. Another limitation could be the long interval between EUS and MRCP executions and between EUS/MRCP and the reference standard reported in some tests, which can favor the passage of stones and disagreement between tests.
An evaluation concerning microlithiasis could not be made because the studies did not contain enough data about the number and sizes of the stones.
CONCLUSION
We have demonstrated that for the same pretest probability of choledocholithiasis, EUS exhibits a higher posttest probability when the result is positive and a lower posttest probability when the result is negative compared to MRCP.
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